It has been proposed that the association between CD47 on tumor cells and thrombospondin-1 on T cells acts as an immunological checkpoint, impairing T cell activation and thereby decreasing antigen-dependent killing of tumor cells by CD8+ T cells (58). This evidence concerns the gene CD47 and neoplasm.